J. David Enloe, Jr
2022
In 2022, J. David Enloe, Jr earned a total compensation of $2.3M as President and Chief Executive Officer at Recro Pharma, a 107% increase compared to previous year.
Compensation breakdown
| Bonus | $400,000 |
|---|---|
| Option Awards | $498,982 |
| Salary | $572,115 |
| Stock Awards | $749,999 |
| Other | $50,444 |
| Total | $2,271,540 |
Enloe received $750K in stock awards, accounting for 33% of the total pay in 2022.
Enloe also received $400K in bonus, $499K in option awards, $572.1K in salary and $50.4K in other compensation.
Rankings
In 2022, J. David Enloe, Jr's compensation ranked 1,591st out of 5,737 executives tracked by ExecPay. In other words, Enloe earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,591 out of 5,737 | 72nd |
Division Manufacturing | 815 out of 3,126 | 74th |
Major group Chemicals And Allied Products | 321 out of 1,416 | 77th |
Industry group Drugs | 298 out of 1,317 | 77th |
Industry Pharmaceutical Preparations | 212 out of 963 | 78th |
Source: SEC filing on April 6, 2023.
Enloe's colleagues
We found one more compensation record of an executive who worked with J. David Enloe, Jr at Recro Pharma in 2022.
2022
Ryan Lake
Recro Pharma